In silico discovery of novel Retinoic Acid Receptor agonist structures

BACKGROUND: Several Retinoic Acid Receptors (RAR) agonists have therapeutic activity against a variety of cancer types; however, unacceptable toxicity profiles have hindered the development of drugs. RAR agonists presenting novel structural and chemical features could therefore open new avenues for...

Descrición completa

Detalles Bibliográficos

Publicado en:	BMC Struct Biol
Principais autores:	Schapira, Matthieu, Raaka, Bruce M, Samuels, Herbert H, Abagyan, Ruben
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2001
Assuntos:	Research Article
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC32304/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11405897/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1472-6807-1-1
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!